0.6582
price down icon1.47%   -0.0098
after-market アフターアワーズ: .64 -0.0182 -2.77%
loading
前日終値:
$0.668
開ける:
$0.651
24時間の取引高:
44,455
Relative Volume:
0.08
時価総額:
$5.20M
収益:
-
当期純損益:
$-6.07M
株価収益率:
-0.1139
EPS:
-5.78
ネットキャッシュフロー:
$-7.34M
1週間 パフォーマンス:
-4.33%
1か月 パフォーマンス:
-4.54%
6か月 パフォーマンス:
-42.77%
1年 パフォーマンス:
-49.76%
1日の値動き範囲:
Value
$0.651
$0.67
1週間の範囲:
Value
$0.646
$0.7392
52週間の値動き範囲:
Value
$0.5704
$3.00

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
名前
Adial Pharmaceuticals Inc
Name
セクター
Healthcare (1168)
Name
電話
434-422-9800
Name
住所
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
職員
7
Name
Twitter
@AdialPharma
Name
次回の収益日
2024-12-12
Name
最新のSEC提出書
Name
ADIL's Discussions on Twitter

ADIL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADIL
Adial Pharmaceuticals Inc
0.6582 5.44M 0 -6.07M -7.34M -5.78
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-14 開始されました Rodman & Renshaw Buy
2018-10-30 開始されました Maxim Group Buy
2018-10-11 開始されました Dawson James Buy

Adial Pharmaceuticals Inc (ADIL) 最新ニュース

pulisher
May 30, 2025

Adial Pharmaceuticals (ADIL) Files to Sell Over 6 Million Shares - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals Faces Nasdaq Non-Compliance Notice - TipRanks

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals (ADIL) Files to Sell Over 6 Million Shares | ADIL Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World

May 30, 2025
pulisher
May 19, 2025

ADIL Q2 EPS Increased by Brookline Capital Management - Defense World

May 19, 2025
pulisher
May 16, 2025

Adial Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 16, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 16, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals sets new proposal deadline By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals sets new proposal deadline - Investing.com

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals (ADIL) Reports Q1 2025 Results | ADIL Stoc - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Resul - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals (ADIL) Reports Q1 2025 Results | ADIL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | ADIL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Q1 2025 Financial Results and Business Update - TradingView

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Advances AUD Drug to Phase 3, Cuts Losses by 66% in Q1 2025 Earnings - Stock Titan

May 15, 2025
pulisher
May 14, 2025

ADIAL PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Adial Pharmaceuticals (ADIL) Receives Milestone Payment for Asth - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Adial Pharmaceuticals (ADIL) Receives Milestone Payment for Asthma Drug Development | ADIL Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study - The Manila Times

May 13, 2025
pulisher
May 11, 2025

Adial Pharmaceuticals (ADIL) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

FDA to Review Adial’s Phase 3 Trial Plan for AUD Treatment - Investing.com Nigeria

May 09, 2025
pulisher
May 08, 2025

FDA Has Granted Request for End of Phase 2 Meeting to Discuss Alcohol Use Disorder Treatment, AD04 - Psychiatric Times

May 08, 2025
pulisher
May 08, 2025

FDA to Review Adial’s Phase 3 Trial Plan for AUD Treatment By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Adial Pharmaceuticals Granted End Of Phase 2 Meeting From FDA - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program - AOL.com

May 08, 2025
pulisher
May 08, 2025

Adial Pharmaceuticals (ADIL) Receives FDA Green Light for Phase 3 Meeting | ADIL Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Purchases New Stake in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) - Defense World

May 08, 2025
pulisher
May 07, 2025

Richmond InnoAdial Pharmaceuticals raises $2.75M - The Business Journals

May 07, 2025
pulisher
May 05, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

May 05, 2025
pulisher
May 05, 2025

ADIL: Adial Pharmaceuticals Boosts Patent Portfolio with New Approval | ADIL Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Geode Capital Management LLC Grows Stock Holdings in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) - Defense World

May 05, 2025
pulisher
May 02, 2025

Adial Pharmaceuticals secures $2.75 million through warrant exercise By Investing.com - Investing.com Nigeria

May 02, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

Adial Pharmaceuticals secures $2.75 million through warrant exercise - Investing.com

May 02, 2025
pulisher
May 02, 2025

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds | ADIL Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Healthcare Investor Commits $2.75M to Adial Pharmaceuticals Addiction Treatment Pipeline - Stock Titan

May 02, 2025
pulisher
May 02, 2025

Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga

May 02, 2025
pulisher
May 01, 2025

Retail Traders Flock To Adial Pharma After Patent News Sends Shares Soaring - Asianet Newsable

May 01, 2025
pulisher
May 01, 2025

Adial Pharmaceuticals Inc: Rising -76.71% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

How will Adial Pharmaceuticals Inc’s (ADIL) earnings compare to estimates this quarter? - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Adial Pharmaceuticals (ADIL) Secures Patent for Novel Addiction Treatment Method | ADIL Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Adial Pharmaceuticals secures patent for addiction treatment - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders - GlobeNewswire

May 01, 2025
pulisher
May 01, 2025

Revolutionary Patent Links Genetic Markers to Personalized Addiction Treatment Success - Stock Titan

May 01, 2025
pulisher
May 01, 2025

EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders - Yahoo

May 01, 2025
pulisher
Apr 28, 2025

Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight - GlobeNewswire Inc.

Apr 28, 2025

Adial Pharmaceuticals Inc (ADIL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
大文字化:     |  ボリューム (24 時間):